PMID
int64 35.7M
36.4M
| Title/Abstract
stringlengths 22
8.78k
| MeshTerms
stringlengths 7
101
| SemanticTypes
stringlengths 4
64
|
|---|---|---|---|
36,306,262
|
survey patient knowledg awar sick day rule rheumatolog patient long term glucocorticoid therapi aim rheumat diseas rmd patient treat long term glucocorticoid gc risk develop tertiari adren insuffici survey aim assess knowledg rmd patient take long term glucocorticoid therapi regard risk adren insuffici understand steroid sick day rule method rmd patient take mg prednisolon daili month recruit rheumatolog outpati depart beaumont hospit dublin patient knowledg previous counsel steroid sick day rule determin use point questionnair carri face face via phone call result rmd patient gc therapi recruit patient report counsel sick day rule carri steroid emerg card medicalert bracelet patient would increas steroid dose appropri respons infect vomit peri procedur respect conclus demonstr signific deficit patient knowledg around precaut long term gc use rheumat diseas suspect result may generalis mani rmd unit current review procedur around healthcar profession patient educ issu inform leaflet emerg card medicalert bracelet etc risk patient
|
D012219;D000309
|
T047;T091
|
36,306,248
|
singl hand helicen nanoribbon via transfer chiral inform show access singl hand helicen nanoribbon util helicen build block induc diastereoselect photochem format helicen unit specif synthes nanoribbon p p differ ratio helicen sergeant helicen soldier averag consist ortho annul benzen ring longest optic activ helicen backbon prepar date chiropt properti p p reveal transfer stereochem inform sergeant soldier gain insight stereo inform relay appli molecular design discret model oligom confirm also preferenti adopt homochir geometri
|
D037742;D011083
|
T104;T073;T109
|
36,306,245
|
examin provinci prep coverag character prep awar use among gay bisexu men sex men vancouv toronto montreal access pre exposur prophylaxi prep canada remain complex public fund coverag deliveri differ provinc januari prep becam public fund free charg british columbia bc wherea prep coverag ontario montreal limit may requir pocket cost examin differ time prep uptak assess factor associ prep awar use
|
D000072339;D015658;D065129
|
T061;T047;T098
|
36,306,238
|
haemophilus influenza type f post haemophilus influenza type b vaccin era systemat review sinc introduct haemophilus influenza hi serotyp b hib vaccin report increas incid rate non hib serotyp emerg systemat review perform investig whether hi serotyp f hif incid rate increas global describ associ diseas burden post hib vaccin era evid show incid rate hif infect increas worldwid total studi includ patient report hif infect estim pool incid rate hif infect popul per year rang median case fatal ratio invas infect frequent present pneumonia septicaemia mening hif isol ampicillin suscept multi locus sequenc type reveal hif relat clonal major belong clonal complex hif caus invas infect signific varianc sever present global hif popul show littl genet variabl current appear possess low resist antimicrobi
|
D019741;D006192;D018073
|
T121;T129;T047;T007
|
36,306,237
|
trend stenotrophomona maltophilia antibiot resist rate unit state veteran affair health system introduct stenotrophomona maltophilia import multidrug resist gram negat pathogen larg hospit acquir pathogen increas report pathogen communiti gap statement trend maltophilia preval resist rate includ outpati isol unknown aim describ recent trend preval resist maltophilia nation veteran affair va healthcar system methodolog studi identifi posit maltophilia clinic cultur among va adult patient across va hospit long term care facilitiesunit outpati set annual maltophilia resist rate evalu multidrug resist mdr defin resist sulfamethoxazoletrimethoprim smxtmp minocyclin levofloxacin time trend assess regress analys estim annual averag percent chang aapc confid interv use joinpoint softwar result year studi period maltophilia cultur identifi hospit long term care outpati common sourc maltophilia cultur respiratori cultur follow urin cultur va hospit long term care facil number maltophilia cultur decreas signific per year respect overal isol mdr remain stabl studi period resist antibiot assess most remain stabl except smxtmp resist decreas signific per year va hospit conclus previous work recogn maltophilia primarili nosocomi pathogen present studi found cultur collect among outpati number posit maltophilia cultur decreas signific nation va healthcar system resist smxtmp decreas studi period va hospit close reflect previous report resist rate worldwid mdr maltophilia remain stabl low nation va healthcar system
|
D020615;D014728;D016905
|
T098;T047;T007
|
36,306,236
|
renal system associ disord disord renal system includ kidney urinari tract increas recognis public health concern account death worldwid patient often comorbid mani present diseas health profession requir good knowledg renal system associ disord creat holist care plan meet individu patient need articl cover pathophysiolog common problem patient assess investig consider help patient self manag
|
D007668;D006282
|
T023;T097
|
36,306,235
|
disinfect needleless connector reduc staphylococcus aureus bacteri load compar effect chemic disinfect reduc aureus five disinfect reduc bacteri load especi chlorhexidin solut focus brazilian clinic practic needleless connector disinfect
|
D004203;D004202
|
T061;T131;T167
|
36,306,234
|
hospit nurs experi end life care provis creativ phenomenolog approach current evid suggest hospit nurs end life care complex due conflict task treatment focus care palliat topic need explor
|
D013727;D017051
|
T058;T093
|
36,306,233
|
evalu daisi diseas attack immun system award recognis excel nurs increas demand nurs servic worldwid onus healthcar system implement measur improv retent daisi award design celebr nurs suggest may improv staff retent
|
D001363
|
T073
|
36,306,232
|
central venous access devic lock practic adult critic care set singl centr observ studi establish durat lock per cathet lumen central line complic remain problem critic care patient popul various intervent prevent treat complic central line associ bloodstream infect occlus focus recent research although altern cathet lock solut shown effect patient popul applic critic care set remain unclear due high acuiti critic care patient uncertain whether central line remain lock durat long enough altern lock solut provid effect
|
D062905;D002405;D055499
|
T061;T074;T046
|
36,306,230
|
nurs led educ intervent reliev idiopath constip retrospect studi constip common condit although numer articl emphasis import conserv intervent none set complet educ programm
|
D024802;D003248
|
T184;T054
|
36,306,228
|
avoid litig complaint good communic practic john tingl lectur law birmingham law school univers birmingham discuss recent patient safeti report focus good communic
|
D013222;D061214
|
T058;T064
|
36,306,227
|
barrier attitud toward use safeti engin devic paediatr cannul emerg care articl describ report attitud toward barrier use safeti cannula paediatr patient evalu prompt lack engag doctor nurs continu use non safeti engin devic non sed safeti engin devic sed introduc paediatr emerg depart ed survey conduct among doctor nurs work paediatr ed question focus particip clinic experi view safeti access train devic prefer provid quantit qualit data find highlight sever issu includ differ opinion profession group toward safe sharp signific differ access train educ doctor nurs also identifi includ date train appear like use sed without recommend includ strategi improv complianc propos plan conduct clinic audit measur complianc later date
|
D011482;D010820
|
T073;T097
|
36,306,226
|
consent requir access inform richard griffith senior lectur health law swansea univers consid import access inform obtain consent patient
|
D012308;D007258
|
T089;T058
|
36,306,224
|
new mandatori train set transform outcom client learn disabl sam foster chief nurs oxford univers hospit report initi centr ensur staff work client group equip requisit knowledg skill provid appropri care
|
D007859
|
T033;T048
|
36,306,220
|
hepatocellular carcinoma suppli inferior phrenic arteri cystic arteri anatom technic consider intra arteri treatment identifi one mainstay manag unresect hepatocellular carcinoma thorough knowledg tumor arteri suppli enabl select therapi improv safeti efficaci inferior phrenic arteri ipa common extrahepat collater arteri feed hepatocellular carcinoma bilater ipa known specif vascular anatomi system pulmonari shunt gastric branch ipa may present confus tumor blush supraceliac aorta celiac trunk common origin site ipa orific may compress diaphragm various techniqu cathet use catheter ipa depend origin site ipa normal connect intercost intern mammari retroperiton hepat arteri hemodynam may alter orific occlud general superselect chemoembol via target branch ipa safe effect system pulmonari shunt ipa adequ embol coil particl radioembol ipa perform safe case cystic arteri branch deep superfici cystic arteri deep cystic arteri often suppli tumor near gallbladd chemoembol cystic arteri relat safe transient embol materi radioembol cystic arteri recent tri accept efficaci toxic result requir investig rsna
|
D006528;D016461;D008113
|
T061;T191
|
36,306,219
|
optim imag pediatr liver lesion guidelin pediatr li rad work group differenti diagnosi base patient age clinic present serum fetoprotein level help guid initi imag workup children liver lesion children vari signific size abil stay still abil breath hold imag examin choos tailor imag techniqu protocol indic age group import optim care minim invas need sedat anesthesia obviat use techniqu like feed bundl distract contrast enhanc us motion insensit sequenc mri us often first imag modal use children suspect abdomin mass hepat lesion confirm multiphas contrast enhanc mri recommend lesion next imag modal allow full character lesion assess liver parenchyma contrast enhanc ct also perform assess pediatr focal liver lesion especi patient contraind mri contrast enhanc us shown promis decreas need mri ct lesion hemangioma focal nodular hyperplasia children histori malign develop multipl type hepat lesion various stage includ infect immunocompromis state manifest focal liver lesion base avail limit data literatur collect experi liver imag report data system pediatr work group author provid guidelin imag workup pediatr focal liver lesion indic age base approach discuss select perform various imag techniqu modal rsna see invit commentari chojniak boaventura issu
|
D006528;D008113
|
T191
|
36,306,218
|
fingerprint mycobacterium tuberculosi isol miru vntr genotyp detect isoniazid resist real time pcr introduct tuberculosi tb great public health problem develop countri egypt genotyp mycobacterium tuberculosi isol promin role field tb prevent aim studi aim evalu real time pcr use minor groov binder mgb probe identifi circul lineagessub lineag tuberculosi transmiss pattern hypothesi hypothes miru vntr techniqu effici identifi circul tuberculosi lineag egypt methodolog fifti sputum specimen posit acid fast bacilli includ isoniazid inh resist detect use proport method real time pcr use mgb probe use simultan detect tb infect inh resist partial sequenc katg gene use confirm inh resist result standard mycobacteri interspers repetit unit variabl number tandem repeat miru vntr approach use genotyp miru vntr plus onlin platform result seven specimen show phenotyp resist inh tuberculosi detect sampl mutat katg gene codon detect five sampl also phenotyp inh resist sequenc katg gene show codon mutat genotyp phenotyp five inh resist isol molecular genotyp tuberculosi isol reveal major isol belong famili lineag low cluster rate observ among isol accord hunter gaston discriminatori index hgdi miru vntr loci high moder discrimin four loci less polymorph conclus miru vntr genotyp reveal low cluster rate low recent transmiss rate tuberculosi strain alexandria egypt
|
D009169;D014376
|
T047;T007
|
36,306,216
|
crispr cas heterogen plasmid incompat type relat virul determin shigella introduct virul factor vfs potent weapon molecular armouri shigella bacteria mobil genet element mges contributor evolut differ type cluster regular interspac short palindrom repeat crispr associ gene crispr cas variant plasmid incompat type present studi explor virul potenti shigella relat crispr cas pattern incompat type among isol hypothesisgap statement profil crispr cas system among clinic isol shigella india report earlier limit knowledg avail pattern plasmid incompat group among clinic isol shigella bias alway toward studi genet element associ amr present studi highlight crispr cas incompat type among shigella associ virul aim aim investig distribut virul factor crispr cas pattern follow plasmid incompat type among shigella isol methodolog total isol shigella includ studi virul gene distribut carri crispr cas profil follow analysi repeat spacer carri pcr base replicon type use determin incompat type interplay statist determin use stata result distribut virul gene show vari pattern ipah present isol follow ompa virf ial en seta setb crispr crispr cas cas region domin conserv twenti two type spacer identifi crispr repeat appear high conserv sequenc crispr least common crispr type show strong associ array virul gene ial seta setb virf crispr domin show least associ virul gene sen virf domin plasmid found belong inc fii group incompat group fii inci u fii fiik k ac ialpha found associ greater number virul gene conclus isol show increas divers gene content contribut increas heterogen among isol known virul strategi among pathogen
|
D064113;D012760
|
T040;T007
|
36,306,207
|
cancer risk follow residenti exposur airborn polychlorin biphenyl danish regist base cohort studi polychlorin biphenyl pcbs biopersist chemic classifi human carcinogen classif primarili base evid higher chlorin pcbs found food carcinogen potenti airborn lower chlorin pcbs remain larg unexplor
|
D011078;D008579;D008577;D008113
|
T131;T191;T109
|
36,306,200
|
norepinephrin modul heat dissip femal rat lack estrogen postmenopaus hot flush caus lack estradiol e neuroendocrin basi still poor understood investig interrelationship norepinephrin hypothalam neuron emphasi kisspeptin neuron arcuat nucleus arc regulatori pathway vasomotor effect e ovariectom ovx rat display increas tail skin temperatur tst increas prevent ovx rat treat e ovx e express fos hypothalamus number arc kisspeptin neuron coexpress fos increas ovx rat likewis brainstem norepinephrin neuron ovx rat display higher fos immunoreact associ increas tst arc densiti dopamin hydroxylas dbh immunoreact ir fiber alter e import dbh ir termin found close apposit kisspeptin cell reveal norepinephrin input arc kisspeptin neuron intracerebroventricular inject adrenerg agonist clonidin clo use reduc central norepinephrin releas confirm decreas methoxi hydroxyphenylglycolnorepinephrin ratio preoptic area arc accord clo treatment ovx rat reduc arc kiss mrna level tst valu ovx e rat convers clo stimul kiss express anteroventr periventricular nucleus avpv increas lutein hormon secret find provid evid augment heat dissip ovx rat involv increas central norepinephrin modul hypothalam area relat thermoregul includ arc kisspeptin neuron neuron network suppress e imbal may implic vasomotor symptom postmenopaus hot flush
|
D059648;D007986
|
T125;T123;T121;T116
|
36,306,199
|
agouti relat peptid neuron silenc overcom delay puberti neonat underf male mice agouti relat peptid agrp neuron thought indirect regul activ hypothalam gonadotrophin releas hormon neuron control fertil agrp neuron also drive calor intak modul metabol relev hormon provid link hypothalam pituitari gonad axi mice express cre depend design receptor dreadd agrp neuron activ silenc neuron vivo use synthet ligand clozapin n oxid cno observ effect agrp neuron activ time puberti valid anim chronic treat stimulatori hmdq inhibitori hmdi dreadd agrp cre mice cno observ pronounc increas decreas food intak respect consist known orexigen effect neuron rnascop perform visual confirm activ agrp neuron puberti onset assess male femal effect preputi separ male vagin open first oestrus femal cno treatment day chronic modul agrp neuron next determin whether delay puberti onset occur respons neonat underfeed could overcom inhibit agrp neuron activ mice rais larg neonat underf normal litter size delay puberti underfeed complet revers cno treat agrp hmdi male mice data highlight inhibitori role agrp neuron delay puberti onset undernutrit occur neonat period least male mice trail registr number jne oar
|
D065468;D044342
|
T047;T015
|
36,306,198
|
pict regul p splice sensit medullari thyroid carcinoma cell everolimus protein interact carboxyl terminus pict nucleolar protein shown act tumor suppressor interact pten contrast manner facilit access p ubiquitin degrad thus function oncogen aim studi examin potenti role pict neuroendocrin neoplasm nen tumorigenesi respons mtor inhibitor treatment pict overexpress medullari thyroid tt pancreat bon nen cell line use lentivir vector wherea bon cell pict overexpress exhibit signific impact tt cell induc appear p lack c terminus end accompani robust decreas p express elev cell viabil remark pict overexpress complet revers reduct cell viabil medullari thyroid neoplasm cell induc everolimus therapeut option patient progress nen mtor pathway investig reveal pict overexpress induc reduct pten express robust increas express level phospho akt ser partial inhibit everolimus find suggest possibl role pict spliceosom machineri provid function involv pict complex network mtor
|
D013964;D016159
|
T123;T191;T116
|
36,306,196
|
metronom chemotherapi patient advanc neuroendocrin tumor singl center retrospect analysi neuroendocrin tumor net common slow grow therefor patient often receiv chronic system therapi tumor growth control preserv qualiti life metronom chemotherapi mct line goal lead stabil tumor growth time without sever system toxic retrospect analysi patient metastat net receiv metronom capecitabin mcap temozolomid mtem net referr center aim studi explor activ safeti mct relationship characterist patient popul clinic outcom among total patient metastat well moder differenti wm net most gastroenteropancreat gep nonfunct year ci median progress free surviv mpfs year ci median overal surviv mos observ diseas control rate grade advers event occur patient mcap mtem most hematolog gastrointestin univari multivari analysi none variabl analyz treatment regimen sex age diagnosi site primari tumor metastas number previous mct line baselin tumor status mct ki valu signific correl os pfs retrospect studi suggest mcap mtem activ well toler patient metastat wm net irrespect primari site site metastas line treatment baselin tumor status
|
D018358
|
T191
|
36,306,194
|
high rate ki increas entero pancreat net relaps surgeri curat intent neuroendocrin neoplasm nen present advanc diseas diagnosi case preclud possibl curat intent surgeri histopatholog heterogen diseas observ inter individu well intra individu diseas cours present studi aim assess frequenc ki chang radic surgeri seri patient radic resect entero pancreat neuroendocrin tumor ep net present analysi multicent retrospect seri ep net g g recur radic resect histolog evalu diseas recurr dr primari endpoint descript ki chang dr compar time surgeri secondari endpoint assess recurr free surviv rfs rate total patient second histolog evalu could includ present studi median ki surgeri rang dr signific increas valu observ rang p involv case correspond increas tumor grade p median rfs overal popul month wors ki increas dr vs stabl ki valu vs month respect p conclus half case relaps radic surgeri higher prolif index potenti aggress potenti observ therefor histolog reassess consid dr tailor therapeut strategi may requir patient
|
D010190;D018358
|
T191
|
36,306,184
|
approach fna pancreat cyst pancreat cyst increas detect imag studi accur determin type cyst import provid appropri care patient also clear one singl modal provid adequ diagnost inform pancreat cyst multimod approach diagnosi pancreat cyst key review highlight approach fine needl aspir pancreat cyst review also highlight salient featur common neoplast pancreat cyst along use ancillari test includ biochem test common util molecular test andor immunohistochem test provid accur diagnosi
|
D010190;D010181
|
T047;T191
|
36,306,178
|
evalu reax forc field studi collis energet proton dna earli dna damag induc ioniz radiat depend ioniz particl transfer energi molecul surround medium most water preliminari studi found energi transfer kev proton cytosin guanin base pair classic simul collis use reaxff potenti much smaller obtain quantum calcul use time depend densiti function theori tddft observ two main reason accur forc field situat problem deal proton charg collis focus interact potenti calibr van der waal energi term reaxff potenti use tddft calcul genet algorithm specif interact proton dna constitu atom carbon hydrogen phosphorus nitrogen oxygen obtain signific improv interact potenti consequ scatter angl proton collid target atom question howev conclud despit improv forc field scatter angl classic charg equilibr method also improv proper describ proton dna collis process
|
D011522;D003596
|
T123;T196;T109
|
36,306,177
|
key factor mechan strength tough orient poli l lactic acid monofila bioresorb self expand stent investig strength tough poli l lactic acid plla monofila essenti fundament element biodegrad braid stent howev determin factor remain poor address respect influenc mechan behavior plla monofila work electron beam eb differ radiat dose util steril plla monofila properti monofila includ break strength elong break molecular weight orient microstructur fractur character result show random chain scission plla result eb process could caus decreas molecular weight led declin break strength meanwhil irradi monofila found almost elong break dose kgi declin dose kgi also found ductil fractur connect monofila translat brittl fractur compar microstructur without steril phenomena could origin destruct long molecular chain connect crystal plate shorter one radiat plla monofila kgi use braid carotid stent compar carotid wallstent plla stent better provid radial support carotid lesion studi provid preliminari experiment refer evalu predict mechan perform plla braid stent
|
D020341;D011091
|
T122;T074;T109
|
36,306,164
|
structur comput electrophysiolog ac ls synthet ion channel comput simul report ac ls synthet ion channel contain residu leu ser ser leu leu ser leu heptad repeat form ion channel upon applic voltag hexamer coil coil bundl initi posit perpendicular membran settl stabl tilt structur like improv contact non polar exterior channel hydrophob core membran tilt bundl remain state subsequ simul near voltag rang mv contrast attempt identifi stabl pentamer structur fail thus support hypothesi channel hexam result mv use reconstruct free energi profil k cl channel done way sever method result molecular dynam md simul combin electrodiffus model two develop recent requir knowledg diffus instead util one side densiti profil committor probabl consist differ method good support util newli develop method reconstruct free energi ion channel flux k account current channel calcul direct md match well total measur current howev current cl somewhat overestim possibl due slight unbalanc forc field involv chlorid current voltag depend also reconstruct way recent develop effici method requir simul singl voltag yield good agreement experi taken togeth result demonstr comput electrophysiolog becom reliabl tool studi channel mediat ion transport membran
|
D007473;D056004
|
T123;T066;T116;T044
|
36,306,163
|
jmm profil staphylococcus epidermidi staphylococcus epidermidi abund commens bacterium human skin despit protect us foreign invad epidermidi exploit human vulner given opportun opportun aris patient immunocompromis biomed implant present opportun colon surfac form biofilm epidermidi one frequent isol organ implant devic bloodstream infect howev epidermidi infect often recalcitr antibiot biofilm associ antibiot toler furthermor emerg spread near pan resist strain consider health concern symptom subclin make diagnosi challeng treatment antibiot ineffici infect prevent remain best strategi avail
|
D013212;D013203
|
T047;T007
|
36,306,160
|
epidemiolog characterist noncommunic diseas malign tumor guiyang china cross section studi studi address chang characterist diseas great import prevent control occurr develop diseas improv health howev studi epidemiolog characterist noncommunic diseas ncds malign tumor mts resid guiyang china lack
|
D000073296;D002583;D013274;D003920;D006973;D016889;D001943;D012004
|
T047;T191
|
36,306,159
|
examin mental workload relat digit health technolog health care systemat review workload health care increas henc mental health issu rise among health care profession hcps digit patient care could relat increas stress level remain unclear whether health inform system system digit health technolog dhts use health care reliev profession whether repres burden mental construct best describ burden technolog mental workload mwl measur method mwl particular relev sensit set
|
D003695;D006282
|
T058;T097;T093
|
36,306,157
|
environment respons gene express dna methyl reveal factor influenc adapt potenti arabidopsi lyrata understand factor influenc plastic genet variat valuabl predict organ respond chang select environ use gene express dna methyl molecular phenotyp studi environment induc variat among arabidopsi lyrata plant grown lowland alpin field site result show gene express high plastic mani gene differenti express field site popul environment respons gene evolv strong select constraint strength purifi select code sequenc high rate adapt evolut low find howev posit select cis regulatori variant like contribut mainten genet variabl environment respons variant segreg distant relat popul contrast gene express dna methyl genic region larg insensit environ plastic methyl chang associ differenti gene express besid gene detect environment effect transpos element tes tes high altitud field site higher express methyl level suggest broad scale te activ compar lowland popul plant nativ alpin environ harbor excess recent te insert observ specif te famili enrich within environment respons gene find provid insight select forc shape plastic genet variat also highlight plastic respons tes rapid creat novel herit variat stress condit
|
D017360
|
T002
|
36,306,146
|
psychophys comput model featur continu motion percept sensori decis make frequent studi use categor task even though featur space stimuli continu recent becom common measur featur percept gradual fashion say studi motion percept across full space direct howev continu report contamin perceptu motor bias examin bias perceptu report compar two respons method first method particip report motion direct motor refer frame move trackbal second method particip use perceptu frame refer perceptu comparison stimulus test bias use three differ version random dot kinematogram found strong systemat bias respons report direct motor frame refer perceptu frame refer systemat bias evid independ respons method also detect systemat mispercept subject sometim confus physic stimulus direct opposit direct confirm use von mise mixtur model estim contribut verid percept mispercept guess import sensit perceptu report method reveal increas level sensori evid perceptu perform increas form higher detect probabl certain condit also form increas precis
|
D009039
|
T041
|
36,306,145
|
relationship drusen height oct biomark atrophi non neovascular amd determin increas drusen height correl predict optic coher tomographi oct biomark atrophi
|
D008268;D015593;D002114
|
T047;T046
|
36,306,144
|
spleen tyrosin kinas contribut mller glial express proangiogen cytokin diabet neurogli dysfunct occur earli progress diabet retinopathi respons diabet hypoxia mller glia secret cytokin growth factor contribut diseas progress studi design examin common signal pathway activ mller glia type pre type diabet
|
D003921;D003924
|
T047;T050
|
36,306,143
|
visual axi stile crawford effect peak show posit correl normal eye cohort studi purpos studi locat visual axi evalu correl stile crawford effect sce peak
|
D017949;D005584
|
T023;T025
|
36,306,142
|
elev igf gh level correl thicker iri wider anterior chamber angl treatment nave acromegali patient compar differ anterior segment biometr deriv anterior segment optic coher tomographi oct treatment nave acromegali patient normal control evalu correl biometr insulin like growth factor igf growth hormon gh level
|
D015812;D000172
|
T047
|
36,306,135
|
kinet humor immunodefici bispecif antibodi therapi relaps refractori multipl myeloma case seri describ kinet humor defici patient relaps refractori multipl myeloma treat bispecif antibodi infecti complic respons covid immun
|
D009101;D018033
|
T121;T129;T191;T116
|
36,306,134
|
associ race area depriv breast cancer surviv among black white women state georgia increas evid suggest low socioeconom status geograph resid disadvantag neighborhood contribut dispar breast cancer outcom howev littl epidemiolog research sought better understand dispar within context locat
|
D001943
|
T191
|
36,306,133
|
covid pandem infant neurodevelopment impair systemat review meta analysi primari studi propos aberr matern antivir immun andor give birth quarantin ongo covid pandem may associ risk neurodevelopment impair ndi offspr
|
D000086382
|
T047;T067
|
36,306,132
|
reliabl valid instrument covid patient report symptom outpati patient report outcom instrument key assess covid relat symptom associ burden howev valid reliabl instrument assess symptom sever progress among outpati covid yet avail
|
D000086382
|
T047;T067
|
36,306,131
|
analysi emerg depart encount among high user health care social servic system covid pandem although general us popul fewer emerg depart ed visit covid pandem pattern use among high user unknown
|
D000086382
|
T047;T067
|
36,306,130
|
risk variant exom children critic ill diagnost genet test lead chang manag pediatr intens care unit genet risk children critic ill nondiagnost exom sequenc es explor
|
D059472;D012131
|
T047;T046;T028
|
36,306,129
|
assess spend patient initi dialysi care despit widespread belief privat insur spend larg amount health care enrolle receiv dialysi data limit past decad preclud comprehens analysi topic
|
D006435;D005102
|
T061;T081
|
36,306,128
|
effect narrat base psychoeduc intervent prepar patient respond acut myocardi infarct random clinic trial despit decad educ effort patient prolong delay seek care symptom acut myocardi infarct ami remain greatest obstacl success manag condit
|
D009203
|
T047
|
36,306,127
|
analysi state medicaid expans access time prenat care among women immigr vs us born dispar exist access time prenat care immigr women us born women exclus medicaid elig base immigr status may exacerb dispar
|
D008484;D054242
|
T089;T064;T098
|
36,306,125
|
everi treasur drop blood transfus requir preterm neonat implement blood conserv strategi observ analyt studi certain morbid inevit preterm infant challeng lie minim anemia prematur multifactori therapi larg depend adult red blood cell transfus rbct inher without problem literatur respect retrospect evalu individu stratagem reduc rbct
|
D062071;D007235
|
T047;T100
|
36,306,124
|
epidemiolog etiolog clinic associ congenit heart diseas identifi congenit rubella syndrom surveil congenit heart diseas chd common congenit malform antenat rubella infect mother genet defect import caus chd attribut exact contribut antenat rubella infect genet caus chd still unknown
|
D012410;D006330;D006345
|
T019;T047
|
36,306,123
|
preval group b streptococcus pregnant women kerala relat neonat outcom prospect cross section studi earli onset sepsi eo neonat scourg contribut morbid mortal promin stakehold recommend univers screen antenat women group b streptococcus gbs intrapartum antibiot prophylaxi iap carrier howev controversi guidelin allow region specif protocol due sociodemograph geograph ethnic differ plan analyz preval gbs rectovagin carriag week gestat effect earli neonat status
|
D013290;D011251;D018805
|
T047;T046
|
36,306,122
|
attitud toward glaucoma genet risk assess unaffect individu integr polygen risk score prs healthcar potenti stratifi individu risk glaucoma across broad popul glaucoma common caus irrevers blind worldwid therefor effect screen glaucoma endors popul high import studi assess attitud unaffect individu toward prs test glaucoma sought identifi factor associ interest test
|
D005901
|
T047
|
36,306,121
|
deep ensembl learn retin imag classif vision impair affect billion peopl worldwid half prevent earli detect treatment current automat screen ocular patholog use convolut neural network cnns retin fundus photograph limit patholog simultan detect multipl ophthalm patholog would increas clinic usabl uptak
|
D000465;D012164
|
T047;T170
|
36,306,120
|
lobbi expenditur us health care sector cross section studi use public avail nonpartisan data evalu trend lobbi expenditur across health care industri
|
D008119;D019981
|
T078;T169;T093;T057
|
36,306,119
|
associ state issu covid vaccin mandat vaccin administr rate us state district columbia us state issu covid vaccin mandat howev associ mandat vaccin rate remain unknown
|
D000086382;D014612
|
T129;T121;T116;T067;T047
|
36,306,118
|
trend racial ethnic dispar barrier time medic care among adult us racial ethnic dispar delay medic care reason direct associ cost care remain understudi
|
D005006;D006630
|
T098;T102
|
36,306,117
|
indigen health inequ aris inadequ transfer system patient critic ill viewpoint describ system deliv emerg care indigen rural communiti strain covid pandem propos polici solut advanc health care equiti
|
D000069576;D006303
|
T058;T080
|
36,306,036
|
biolog product xylitol use nonconvent microbi strain xylitol c h amorph sugar alcohol crystallin textur receiv great interest global market due numer applic differ industri addit high anticariogen sweeten properti characterist high solubl stabil low glycem index confer xylitol fame food odontolog industri moreov also serv build block product polym result harm effect chemic product xylitol biotechnolog mean produc polyol evolv decad contrast high consumpt energi long period purif special equip high product cost encount chemic synthesi biotechnolog product xylitol offer advantag economi environ non saccharomyc yeast strain also term nonconvent possess inher capac util xylos sole carbon sourc unlik saccharomyc speci
|
D014993;D014994
|
T121;T123;T109
|
36,306,032
|
recent advanc use dimethyl sulfoxid synthon organ chemistri dimethyl sulfoxid dmso extrem import aprot polar solvent reaction medium attract widespread attent chemist recent year due wide rang use multipl function display various chemic process especi past decad dimethyl sulfoxid becom increas favor synthon organ chemistri result great progress research field context review provid comprehens summari literatur recent progress organ synthesi use dimethyl sulfoxid synthon cover report januari may type reaction main perform transfer one unit dimethyl sulfoxid oxygen methyl ch methylen ch methyliden ch methin ch donor formyl cho sulfur methylthio sme methyl sulfoxid donor methyl thiomethyl ch sme donor methyl sulfoxid methyl ch target molecul time hope review stimul futur studi promot develop area
|
D004121;D002625
|
T090;T121;T197;T109
|
36,306,019
|
drought toler sphingobacterium changzhouens alv associ alo vera mediat drought toler maiz zea may drought sever durat expect increas result ongo global climat chang therefor find solut help plant deal drought stress improv growth face limit water resourc critic studi drought toler plant growth promot endophyt bacterium isol alo vera root identifi sphingobacterium changzhouens base rrna gene sequenc deposit ncbi databas access number effect changzhouens inocul maiz growth drought stress investig result reveal inocul signific p enhanc root shoot elong respect photosynthesi rate stomat conduct water use effici improv inocul plant interest inocul result signific increas total chlorophyl total carbohydr prolin total protein total phenol total flavonoid respect total antioxid capac inocul plant mgg fw higher non inocul plant mgg fw found posit correl level phenol flavonoid find suggest changzhouens could use improv crop growth assist plant resist drought stress arid agricultur land
|
D055864;D000504
|
T070;T002
|
36,306,018
|
cardiotox link anticanc agent cardioprotect strategi chemotherapi main treatment cancer benefit patient control cancer relaps metastasi therebi lead increas overal surviv rate howev treatment associ mild sever side effect one cardiotox sever cardiotox lead caus cardiovascular diseas depend type cancer therapi employ time requir manag chemotherapeut agent use either alon combin drug cancer treatment exact mechan chemotherapeut agent induc cardiotox remain unclear although like multifactori includ oxid stress apoptosi inflamm mani approach avoid untoward effect chemotherapeut agent howev avail option cardiac protect minim includ renin angiotensin system blocker beta blocker herbal drug iron chelat dexrazoxan present review provid inform molecular mechan chemotherapi induc myocardi infarct cardiotox along scientif studi synthet molecul herbal extract natur product manag chemotherapi induc cardiotox
|
D000970;D009369
|
T121;T191;T109
|
36,306,017
|
inhibit autophagi chloroquin dysregul mitochondri qualiti control energet adipocyt autophagi complex degrad pathway damag dysfunct protein organell remov pharmacolog modul extens use wide rang basic research preclin studi howev effect inhibitor metabol addit autophagi inhibit fulli elucid chloroquin clinic relev compound inhibit autophagi prevent fusion autophagosom lysosom studi aim examin effect chloroquin mitochondri qualiti control respiratori function util l mous adipocyt treat chloroquin various time point found chloroquin could disturb gene relat mitochondri fission biogenesi mitophagi lead mitochondri dna damag although inhibit autophagi chloroquin result increas prohibitin express respiratori function downregul time depend manner moreov chloroquin treatment induc oxid stress apoptosi metabol dysregul data demonstr chloroquin signific affect mitochondri respiratori function metabol consist impair mitochondri qualiti associ autophagi inhibit
|
D002738;D001343
|
T121;T043;T109
|
36,306,016
|
omic approach reveal effect obes protein profil exosom deriv differ adipos depot obes affect cargo packag adipocyt deriv exosom furthermor adipocyt differ adipos tissu differ genet makeup cargo content exosom deriv differ adipos tissu obes condit differ henc impact pathophysiolog condit
|
D055354
|
T026
|
36,306,014
|
structur function n termin extens formin inf inf formin link inherit renal neurolog diseas human preced short n termin extens unknown structur function inf activ achiev ca depend associ calmodulin cam show n termin extens inf organ two helic first necessari maintain perinuclear f actin ring normal cytosol f actin content biochem assay indic helix interact direct cam contain sole cam bind site camb detect inf residu w l l inf arrang motif identifi import residu bind w critic three motif conserv vertebr inf human popul nmr biochem analys reveal cam interact direct c termin lobe inf camb unlik control cell inf ko cell lack perinuclear f actin ring littl cytosol f actin content respond increas ca concentr make f actin maintain transcript cofactor mrtf predomin cytoplasm wherea express intact inf restor defect inf inactiv camb studi reveal structur n termin extens interact ca cam function inf activ
|
D000199;D008840
|
T123;T116
|
36,305,980
|
bifurc analysi singl popul model advect paper dynam singl popul model general growth function investig advect environ show exist nonconst posit steadi state give suffici condit occurr hopf bifurc posit steadi state moreov theoret result appli diffus nicholson blowfli mackey glass model advect delay respect numer show popul densiti decreas increas advect rate death rate delay induc hopf bifurc like occur small advect low mortal rate
|
D008954
|
T075
|
36,305,977
|
noncoval interact solut metal free one pot asymmetr synthesi aryl dihydro h quinolon quinolon compos remark class compound show various pharmacolog applic particular activ r enantiom aryl dihydro h quinolon made object befit interest asymmetr synthesi although readili yield racem mixtur one pot reaction aminoacetophenon benzaldehyd pathway metal free enantioselect one pot synthesi isom complet clear present work guid burgeon role organocatalysi asymmetr synthesi recent experiment insight like reaction mechan report silico screen roster macmillan chiral imidazolidinon quantum mechan calcul two stereopredict model yield similar high expect ee propos role aromat interact control enantioselect system studi well pro si enantiofaci attack activ energi found correl well r report brgi dunitz angl expect intramolecular mannich reaction mechan
|
D015363
|
T109
|
36,305,975
|
epistem object use sentienc criterion moral status flaw accord common view sentienc necessari suffici moral status word whether intrins moral relev determin capac conscious experi epistem object deriv profound uncertainti sentienc accord object use sentienc criterion ascrib moral status practic wo nt know forese futur anim ai system sentient ethic question regard possess moral status urgent therefor need formul altern criterion argu epistem object dissolv one clear distinguish question determin moral status criterion employ practic ascrib moral status epistem concern irrelev former question argu criteria moral status inescap base sentienc one conced sentienc determin moral status follow doubt epistem access sentienc use motiv altern criterion moral status sentienc turn unknow moral status unknow howev briefli advoc strong pessim
|
D000072577;D009014
|
T078
|
36,305,957
|
character exposur respons relationship ipatasertib patient metastat castrat resist prostat cancer ipatenti studi exposur respons relationship efficaci safeti ipatasertib select akt kinas inhibitor character use data collect patient metastat castrat resist prostat cancer ipatenti studi nct
|
D064129
|
T191
|
36,305,955
|
global catastroph risk driver scientist attitud toward polici anthropogen global catastroph risk human induc risk threaten sustain wide scale loss life damag civilis across globe order understand new research govern mechan emerg technolog might assuag risk import ask percept belief attitud toward govern global catastroph risk within research communiti shape conduct potenti riski research aim studi deepen understand emerg technolog research cultur relat global catastroph risk shed new light new research govern mechan might develop analys depth interview lead ai biotech research univers privat sector develop new insight term four salient theme first engin mindset highlight premium place mani interviewe pursu interest research physic world sake second self govern look self regul technolog develop current occur third pure incent focuss career incent shape research fourth norm persuas examin role moral consider guid research choic scientist end consid implic find futur research govern anthropogen global catastroph risk
|
D006076;D001290
|
T078;T092;T055;T041
|
36,305,954
|
digit filter dissemin optim imped cytometri signal qualiti count accuraci improv biosensor perform util imped cytometri high interest research topic mani clinic diagnost set develop sensor design extern factor rigor optim improv signal qualiti interpret usual still necessari produc sensit accur product common solut involv digit signal process sampl analysi method frequent fall short provid meaning signal outcom chang shortcom may aris lack investig research select use signal process function mani choic current sensor base either theoret result estim hypothes ubiquit condit set improb across divers imped cytometri design lie need streamlin rapid analyt method discov condit uniqu sensor herein present comprehens dissemin digit filter paramet appli experiment imped cytometri data determin limit signal process signal qualiti improv various filter order cutoff frequenc filter type appli data collect highest achiev nois reduct design fabric microfluid imped cytomet polystyren particl measur flow signal qualiti improv db implement digit filter approach translat isol human neutrophil similar signal qualiti improv db compar unfilt origin data sweep filter condit devis system evalu filter perform signal qualiti object count accuraci may serv framework futur system determin appropri optim filter configur
|
D044085;D015374
|
T090;T059;T075
|
36,305,948
|
coastal ramsar site transit hypoxia track pollut sourc case studi south west coast india coastal lake estuari consid econom driver coastal communiti deliv invalu econom ecosystem servic coastal ecosystem face recurr hypoxia event dissolv oxygen mg l emerg major threat ecosystem structur function ashtamudi lake area km one ramsar site state kerala locat sw coast india waterway extens use backwat tourism fisheri activ paper discuss spatio tempor variat water qualiti attribut emphasi hypoxia non monsoon monsoon season extent hypoxia fisheri divers discuss southern zone adjac urban area show hypox condit higher concentr bod n nh n hypox condit larg limit southern zone season occurr low lake high relat salin organ load lake system track pollut sourc lake system also done identif pollut potenti zone found catchment adjac southern western zone urban region major sourc pollut studi suggest hypoxia chiefli attribut anthropogen intervent form discharg wast lake caus overload nutrient organ effluent decreas freshwat suppli absenc proper freshwat mix dilut effluent discharg nearbi urban center
|
D017753;D004784
|
T070;T082;T057
|
36,305,940
|
effect support care prevent peri implant diseas brnemark protocol rehabilit retrospect cohort studi retrospect cohort studi aim evalu effici support periodont treatment spt peri implant diseas prevent total rehabilit patient implant select maxillari mandibular brnemark type protocol four system place privat practic year follow studi particip divid adher spt regular interv two time year group irregular interv year without attend spt group implant place evalu clinic radiograph assess peri implant diseas preval mucos peri implant total popul implant implant respect group higher rate mucos implant peri implant implant group implant respect p odd ratio peri implant group result suggest patient regular receiv spt lower chanc develop peri implant diseas
|
D057873;D052016;D015921
|
T047;T046;T074
|
36,305,939
|
modifi techniqu induc gingiv growth around compromis teeth prior implant placement report two case regen reconstruct periodont plastic surgeri import option treat margin tissu recess indic root coverag periodont procedur prior implant placement among avail procedur periodont flap subepitheli connect tissu graft ctg common treatment option achiev proper tissu manipul present studi propos modif previous techniqu induc spontan gingiv growth around teeth extract prior implant placement success reduct buccal root surfac success reduct root surfac perform diamond bur reduct creat space gingiv tissu grow coron reduc root convex consequ stimul heal process format granul tissu differenti keratin tissu present techniqu suggest improv esthet outcom case involv tooth extract implant placement extract socket immedi load interim restor ctg
|
D005889;D015921
|
T047;T046;T074
|
36,305,938
|
implant placement simultan guid bone regener use advanc platelet rich fibrin deprotein bovin bone miner year retrospect compar studi lack bone volum may compromis correct three dimension implant placement studi design evalu clinic radiograph outcom simultan horizont guid bone regener gbr perform use autogen bone blood deriv product mix bone xenograft studi popul consist patient oper use one two clinic protocol gbr group use autogen bone mix bone xenograft group b use advanc platelet rich fibrin prf mix bone xenograft primari outcom clinic gain peri implant defect secondari outcom includ analysi postop heal periodont paramet margin bone loss occurr advers event surgeri carri success one patient group experienc case earli implant loss three patient one group two group b present biolog complic mean peri implant vertic defect height baselin group group b mm mm respect p statist signific differ mean residu defect height p postop wound heal p observ stabl peri implant margin bone level record load group use prf combin particul bone xenograft cover fix collagen membran may provid clinic result similar obtain via autogen bone mix bone xenograft
|
D000073183;D015921;D001688
|
T121;T123;T122;T074
|
36,305,937
|
xenogen acellular dermal matrix treatment multipl gingiv recess associ partial restor noncari cervic lesion studi evalu use xenogen acellular dermal matrix xadm combin modifi coron advanc flap mcaf partial resin composit fill anatom crown plus mm root surfac treat multipl type gingiv recess associ b noncari cervic lesion nccls studi includ recess patient bleed probe probe depth combin defect height relat gingiv recess clinic attach level esthet dentin hypersensit record month treatment provid statist signific outcom reduc combin defect height mm increas clinic attach level mm increas keratin tissu thick mm shallow probe depth seen signific dentin hypersensit reduct esthet improv observ therefor xadm associ mcaf partial restor might promis altern autogen graft use treat multipl gingiv recess associ b nccls
|
D005889;D062088;D003807
|
T047;T046;T024
|
36,305,936
|
evalu long term efficaci forc erupt teeth restor purpos clinic retrospect studi retrospect studi evalu long term stabil teeth orthodont treat forc erupt restor purpos total particip total orthodont extrud teeth includ studi measur clinic paramet includ pre posttreat radiograph activ time retent time total treatment time addit treatment requir restor teeth pre postsurg complic result show surviv rate forc erupt teeth failur rate due nonrestor cari mm extrus complet statist signific higher chanc tooth requir addit surgeri p complic treatment higher clinician without orthodont train vs clinician orthodont train forc erupt prosthet treatment implant site develop viabl treatment option success long term
|
D050793
|
T061
|
36,305,935
|
reconstruct maxillari sinus previous major sinus elev failur studi year follow fourteen maxillari sinus reconstruct patient present previous sinus elev failur case larg perfor sinus membran occur remov fail graft sinus perfor seal fibrin glue site graft use homolog fibrin glue hfg mix calcium phosphat scaffold cps histolog analys reveal cps hfg graft follow ossif process format spongi bone similar normal skeleton twenti four endoss implant success place newli regener bone implant success restor ceram crown month placement year follow infect implant failur report describ techniqu offer sever clinic advantag remov fail graft sinus perfor repair sinus elev achiev surgeri without need postpon regen surgeri phase
|
D008443;D015921
|
T074;T030
|
36,305,934
|
human histolog analysi implant osseointegr heal site graft nondeminer autolog tooth deriv graft materi autolog tooth deriv graft atdg gain popular bone substitut biomateri owe promis heal dynam vivo patient prefer repurpos hopeless teeth nonetheless concern exist regard biolog respons atdg prepar implant placement subsequ osseointegr week extract socket heal implant acid etch surfac place use osseodensif osteotomi prepar retriev week integr histolog analysi reveal direct bone implant contact multipl region interest along implant surfac residu dentin particl scarc never found contact implant suggest atdg interfer implant osseointegr despit overal trabecular structur adjac maxillari bone larg marrow space implant surfac delin continu dens miner zone thick cell layer vital osteoblast lacuna result suggest heal dynam atdg well align implant osseointegr dynam
|
D015921;D018786
|
T122;T074
|
36,305,933
|
compar assess bovin versus porcin xenograft augment random prospect cohort studi studi compar bone turnov volum stabil bovin deriv xenograft cerabon vs porcin deriv xenograft mineross xp horizont ridg augment hra veneer contour extract socket preserv esp month follow particip divid group hra bovin group hra porcin group esp bovin group esp porcin buccolingu ridg width measur cbct scan baselin month repres histolog core sampl taken esp group month group compris subject subject total buccolingu width group increas mm mm p mm mm p respect howev buccolingu width group decreas mm mm p mm mm p respect signific lower dimension chang note group month porcin xenograft serv stabl biocompat osteoconduct bone substitut expand clinician choic bone graft dental applic
|
D000540;D016301
|
T061;T047
|
36,305,932
|
potenti role titanium allergi implant failur implant bone loss implant failur grow concern case possibl factor lead bone loss may allergi titanium ti report exist literatur ti allergi factor implant loss review current view potenti role implant bone loss discuss case report implant loss retreat patient potenti ti allergi intoler present clinic analyz subsequ success ceram implant may support find ti allergi intoler unfortun lack prospect clinic trial lack reliabl test ti allergi make imposs clinic verifi whether ti allergi play part implant bone loss
|
D006967;D015921
|
T046;T074
|
36,305,931
|
stage approach frenectomi follow modifi tunnel subepitheli connect tissu graft singl mandibular anterior recess clinic report three case case report propos uniqu approach manag cairo gingiv recess type rt rt respect mandibular anterior region anatom featur high frenal attach shallow vestibul preclud use coron advanc flap three system healthi patient present cairo rt rt gingiv recess includ recess manag stage approach frenectomi follow modifi tunnel combin connect tissu graft signific root coverag achiev three case treatment approach allow root coverag relief frenal pull keratin tissu gain increas vestibular depth challeng cairo rt rt gingiv recess mandibular anterior teeth short term follow month show stabl result present case
|
D005889
|
T047;T046
|
36,305,930
|
retrospect outcom horizont guid bone regener partial edentul site facial orient crestal incis foci design retrospect studi aim describ facial orient crestal incis foci assess incid flap dehisc efficaci simultan stage guid bone regener gbr procedur data patient treat foci gbr analyz primari outcom analyz rate initi wound closur secondari outcom relat clinic paramet includ mean resolut dehisc fenestr crestal buccal bone thick bbt bone width bw increas total implant place initi wound closur rate patient implant level respect complet dehisc resolut rate mean dehisc reduct mm ci mm bbt mean increas mm ci mm final bbt averag mm ci mm last bw increas averag mm ci mm stage case util foci partial edentul site help achiev maintain wound closur horizont gbr procedur
|
D015921;D009066
|
T033;T074
|
36,305,929
|
long term follow esthet demand case use slow orthodont extrus case report intern root resorpt lesion maxillari right central incisor treat orthodont extrus improv surround soft hard tissu simultan extract socket preserv perform month heal guid bone regener perform implant place second surgic phase flap coron advanc connect tissu graft place emerg profil model provision crown final crown result success well maintain year follow period hard soft tissu level stabl sign inflamm observ
|
D050793;D007180
|
T061;T023
|
36,305,928
|
histomorphometr analysi flapless place earli load one piec mini dental implant overdentur patient mini dental implant mdis afford altern overdentur medic compromis patient reduc bone volum human studi report histomorphometr analysi earli load flapless place taper one piec mdis ilz southern implant sa month function patient agre addit mdi place remov evalu mdi stabil assess via periotest prior implant remov histolog section four mandibular three maxillari mdis surround bone process bone implant contact bic analyz retriev mdis function month clinic healthi mean probe pocket depth mm mm maxilla mandibl respect periotest valu indic clinic stabil screw thread fill bone reveal intim bic without sign interven fibrous tissu layer arch mean bic larg osteocyt could identifi calcifi tissu indic matur peri implant bone conclud mdis load within week either arch provid proper clinic stabil high bic month
|
D003828;D015921
|
T074
|
36,305,927
|
periosteum classif flap advanc techniqu around mental foramen various surgic flap advanc techniqu bone regener describ literatur howev clinic challeng manag tissu contain scar embed foreign materi thorough describ especi around metal foramen fibrot thicken scar periosteum well mental foramen restrict tissu respond way nativ tissu therefor addit consider approach must consid achiev tension free flap closur articl present flap advanc classif describ three common clinic scenario base periosteum soft tissu qualiti provid surgic approach tissu manag classif focus flap advanc around mental foramen
|
D010521;D000080383
|
T023;T024
|
36,305,926
|
evalu subepitheli connect tissu graft versus acellular dermal matrix modifi coron advanc tunnel techniqu treatment multipl gingiv recess random parallel design clinic trial addit graft materi tunnel procedur yield stabl outcom tunnel procedur alon current avail evid effect graft materi studi compar two graft materi subepitheli connect tissu graft sctg acellular dermal matrix adm modifi coron advanc tunnel techniqu mcat manag multipl adjac gingiv recess magr patient n recess type magr site random alloc treatment admmcat test group sctgmcat control group clinic paramet record baselin treatment month postsurgeri includ gingiv recess depth grd gingiv recess width grw gingiv thick gt keratin tissu width ktw probe pocket depth ppd clinic attach level cal percentag root coverag patient esthet satisfact postop pain record use visual analogu scale vas month signific reduct grd mm mm grw mm mm increas gt mm mm gain cal mm mm record test control group respect howev control group show ktw gain p increas gt p test group patient satisfact esthet outcom month treatment differ test vas score control vas score group p use adm may repres altern sctg use conjunct mcat
|
D005889;D062088
|
T047;T046;T024
|
36,305,925
|
use botulinum toxin surgic lip reposit random clinic trial studi aim determin whether administ botulinum toxin type bt prior surgeri would stabil surgic lip reposit random control parallel group clinic trial perform total particip excess gingiv display egd divid two group test group tg bt inject smile muscl locat day surgic procedur control group cg lip reposit surgeri perform gingiv display gd upper lip displac ld measur month postop data submit anova tukey test gd ld chang statist signific measur taken baselin month month mark gd present reduct mm tg mm cg month ld measur reduc tg cg month inject bt day lip reposit surgeri provid stabl result effect reduc gd month
|
D005890;D001905
|
T061;T121;T116;T131
|
36,305,924
|
combin periodont orthodont treatment sever compromis teeth stage iv periodont patient far go retrospect studi evalu effect combin periodont orthodont treatment term clinic radiograph patient report outcom stage iv periodont patient advanc attach loss patholog migrat anterior teeth full mouth periodont paramet record baselin diagnosi end activ periodont therapi apt complet orthodont tooth movement otm last support periodont care spc visit radiograph analysi perform total teeth lost apt includ molar use orthodont anchorag premolar due root fractur anterior migrat teeth function mean durat year signific mean probe pocket depth reduct mm attach level gain mm observ apt wherea otm spc associ further small chang alveolar bone level slight increas valu patient report outcom measur signific improv term esthet masticatori function otm consid essenti part comprehens treatment plan chang prognosi sever compromis teeth stage iv periodont patient
|
D010518;D014070;D016388
|
T047;T020;T023
|
36,305,923
|
chang peri implant soft tissu thick bone graft dermi allograft part iii case seri use novel hybrid implant design subcrest angl correct compar case seri present consecut place tempor immedi implant maxillari esthet zone implant novel invert bodi shift design intend achiev high level primari stabil via taper apic portion coron narrow cylind provid greater space implant platform facial socket wall adjac teethimpl allow greater opportun augment restor platform also featur subcrest angl correct facilit screw retent wider facial platform shift thus creat room augment via dual zone bone graft applic dermal allograft yield greater soft tissu thick initi heal case seri aim evalu soft tissu thick compar result two previous publish cohort implant design serv variabl group
|
D057893;D015921;D019250
|
T061;T074
|
36,305,922
|
prospect random control multicent evalu extract socket manag compar wound dress soft tissu substitut postextract bone graft implant placement help preserv alveolar bone volum collagen wound dress soft tissu graft substitut may help protect extract socket bone graft provid better gingiv contour random control multicent doubl blind studi conduct compar control wound dress test soft tissu graft substitut near intact extract socket test control socket graft xenogen bone graft graft contain extract socket soft tissu gap closur gingiv contour gingiv thick examin week time implant place heal unev group signific differ p time requir close extract socket soft tissu gap site close week bone graft cover contain longer test group week vs week less contour disrupt week howev implant placement soft tissu contour group compar soft tissu thick signific differ
|
D020390;D014081
|
T061;T023
|
36,305,921
|
surgic orthodont manag ectop labial impact maxillari canin case seri maxillari canin second common impact teeth two third impact canin palat one third labial impact maxillari labial impact compris approxim general popul like palat impact prevent intercept method employ help impact tooth erupt avoid surgic uncov earli extract appropri primari teeth palat expans help impact erupt spontan labial impact canin posit slot midalveolar locat later incisor first premolar erupt prevent intercept mean manag simpl close erupt uncov techniqu difficult labial impact ectop posit usual horizont posit mesial later incisor apic posit near base nose near midlin rarest labial impact occur central later incisor premolar extrem rare requir special orthodont uncov techniqu ectop impact requir techniqu leav impact tooth uncov orthodontist employ proper mechan move teeth without damag adjac structur articl elucid surgic uncov techniqu orthodont mechan success move teeth minim root resorpt bone loss recess
|
D014095;D012391
|
T047
|
36,305,897
|
medic informat initi rare diseas next generat routin data diagnosi therapi select research peopl rare diseas rds particular potenti benefit digitis healthcar system nation action allianc peopl rare diseas nams campaign se specif taken account digitis healthcar system germani topic address within medic informat initi mii feder ministri educ research bmbf start univers hospit digit infrastructur current establish data protect compliant multipl use standardis care research data sinc part initi cord mi project collabor rare diseas univers hospit partner throughout germani join forc improv patient care research field rare diseasesthi articl highlight mii take account concern se opportun new routin data obtain offer se modul includ mii core data set inform model base data standard fast healthcar interoper resourc fhir data collect context care research routin thus exchang particip institut futur support exampl diagnosi therapi select research project field se cord mi project set goal obtain insight care situat peopl se help exemplari question draw conclus necessari step area digitalis
|
D035583;D008490
|
T047;T091;T066
|
36,305,893
|
new rout enantio sensit structur determin photoelectron scatter molecul gas phase x ray well electron diffract power tool structur determin molecul studi random orient molecul gas phase address case molecular crystal generat interact free molecular structur address studi usual yield partial geometr inform interatom distanc present complementari approach allow obtain insight structur handed even detail geometr featur molecul gas phase approach combin coulomb explos imag inform encod molecular frame diffract pattern core shell photoelectron ab initio comput use loop like analysi scheme abl deduc specif molecular coordin sensit even handed chiral molecul posit individu atom eg proton
|
D004583
|
T081;T196
|
36,305,891
|
pyruv prevent onset cachect featur metabol alter myotub downregul stat signal cachexia system diseas associ sever patholog includ cancer lead excess weight loss due enhanc protein degrad previous show cachect featur myotub provok metabol shift toward lactic ferment previous result led us hyphotesis increas pyruv concentr could imped metabol modif respons induct cachexia myotub demonstr addit sodium pyruv condit media ct colon cancer cell cm ct prevent onset either phenotyp metabol cachect featur myotub treat cm ct contain sodium pyruv show phenotyp similar healthi counterpart display lactat product oxygen consumpt pyruv dehydrogenas activ control myotub use mitochondri pyruv carrier inhibitor uk highlight import mitochondri pyruv amount prevent cachexia inde uk treat myotub show cachect featur observ myotub treat cm ct final found sodium pyruv abl decreas stat phosphoryl level signal pathway involv induct cachexia myotub collect result show cachexia myotub could prevent util sodium pyruv imped metabol modif respons acquisit cachect featur
|
D002100;D019289
|
T184;T121;T123;T109
|
36,305,884
|
pre endoscopi symptom age esophag biopsi number associ post endoscopi advers event esophagogastroduodenoscopi egd frequent util investig tool manag gastrointestin condit children biopsi obtain egd may pose risk post oper advers event ae understand risk imper provid inform consent famili safe patient care particular impact biopsi number locat develop ae studi pediatr patient prospect assess ae telephon survey day egd perform patient age year year period demograph endoscop histolog data collect common symptom report throat pain chest pain dysphagia binari regress model identifi age pre oper symptom factor influenc likelihood post oper morbid multipl biopsi differ locat esophagus impact risk post oper ae
|
D016099;D003680
|
T061;T058;T047
|
36,305,883
|
racialethn dispar manag pediatr acut pancreat across children hospit racial ethnic dispar health care deliveri resourc util report varieti pediatr diseas acut pancreat ap associ black race increas inpati mortal data associ race ethnic resourc use manag pediatr ap lack aim studi investig potenti associ pediatr ap
|
D005006;D010195
|
T047;T098;T102;T046
|
36,305,882
|
budesonid gluten contain elimin diet treatment non respons celiac diseas children non respons celiac diseas nrcd defin patient persist symptom enteropathi marsh histolog suggest activ celiac diseas ced follow gluten free diet gfd least month nrcd suggest affect children ced data limit research date describ treatment children condit aim studi describ center approach identifi treat nrcd budesonid gluten contain elimin diet gced
|
D002446
|
T047
|
36,305,881
|
provid constip action plan famili children constip decreas health care util evalu whether provid constip action plan cap famili children constip outpati gastroenterolog gi visit affect health care util gi depart
|
D004636;D010342
|
T073;T080;T055;T093;T058
|
36,305,880
|
tachygastria preterm infant longitudin cohort studi tachygastria gastric dysrhythmia cycl per minut cpm associ gastric hypomotil gastrointestin disord healthi preterm infant spend time tachygastria adult howev normat valu defin sought determin percent time preterm infant spend tachygastria
|
D007234;D013270
|
T033;T023;T100
|
36,305,874
|
platelet deriv tlt promot tumor progress suppress cd cell current understand tumor immunosuppress mechan form basi modern day immunotherapi immunoregulatori role platelet cancer remain larg elus platelet non small cell lung cancer nsclc patient reveal distinct activ phenotyp trem like transcript tlt platelet protein increas along enhanc extracellular releas nsclc platelet increas platelet tlt also evid human mice patient deriv tumor immunocompet mice syngen tumor tlt bind cell vivo led suppress cd cell promot tumor growth identifi direct interact tlt cd cell implic nf b pathway cd cell suppress anti tlt antibodi rescu patient cell platelet induc suppress ex vivo reduc tumor mice vivo clinic higher tlt correl reduc surviv nsclc patient find thus identifi tlt platelet deriv immunosuppressor suppress cd cell demonstr therapeut prognost signific cancer
|
D002289;D008175
|
T191
|
36,305,871
|
electrochem strategi proton relay instal enhanc activ hydrogen evolut electrocatalyst new method instal proton relay enhanc reactiv near activ catalyt site h product report afford electrochem reduct proton one ligand paddlewheel rh ii ii hydrogen evolut complex cis rh dphf bncn rh bncn dphf n n diphenylformamidin bncn benzo c cinnolin electrochem revers prewav observ rh bncn potenti posit first bncn center reduct coupl presenc strong acid observ v vs fc fc ferrocen cyclic voltammogram cvs dmf tbapf origin prewav shown aris precatalyt transform origin concert proton electron transfer cpet event occur one bridg bncn ligand electrochem analysi cv simul electron structur calcul reaction mechan elucid system electrochem form n h bond reduc bncn ligand serv proton relay h format reaction cooper interligand pathway involv one bridg dphf ligand second reduct step access approxim v vs fc sinc calcul show hydrogen evolut take place bridg ligand involv dirhodium core predict abund metal center incorpor ligand scaffold lead new candid electrocatalyt hydrogen reduct work delin new design strategi incorpor proton relay molecular bimetal hydrogen evolut electrocatalyst achiev higher effici
|
D006859;D006864
|
T196;T126;T116
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.